U.S. Global Investors (USGI)’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-40,814
Closed -$969K 168
2020
Q2
$969K Hold
40,814
0.09% 61
2020
Q1
$703K Sell
40,814
-31,138
-43% -$570K 0.19% 57
2019
Q4
$1.27M Buy
71,952
+13,472
+23% +$228K 0.57% 55
2019
Q3
$1.03M Buy
58,480
+5,121
+10% +$104K 0.56% 60
2019
Q2
$1.14M Buy
53,359
+31,047
+139% +$651K 0.59% 49
2019
Q1
$531K Buy
+22,312
New +$509K 0.25% 91

Other funds holding EXEL

U.S. Global Investors (USGI)'s EXEL Position: Q3 2020 in Review

U.S. Global Investors (USGI) sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 40,814 shares — an estimated $969K sold.

U.S. Global Investors (USGI) first reported a position in EXEL in Q1 2019 and held it in 6 quarters. The position peaked at $1.27M in Q4 2019. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

  • U.S. Global Investors (USGI) reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 40,814 Exelixis shares in Q3 2020, an estimated $969K.
  • U.S. Global Investors (USGI) first reported a position in Exelixis in Q1 2019 and held it in 6 quarters.
  • U.S. Global Investors (USGI)'s Exelixis position peaked at $1.27M in Q4 2019.
  • 367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2020, filed 13 Nov 2020.